Slide 1
Improving Health is Our Policy
Orange Line

We’re innovative thought leaders and determined advocates who partner with visionary organizations to change health care.

We’re innovative thought leaders and determined advocates who partner with visionary organizations to change health care.

We’re innovative thought leaders and determined advocates who partner with visionary organizations to change health care.

previous arrow
next arrow

Impact Health is a mission-driven health policy and strategic consulting firm dedicated to improving health and well-being for all.

OUR SERVICES

Strategic consulting, policy development, in-depth research, and political analysis.

Everything you need to know about Federal policies impacting your work.

Strategy

Strategic Planning

Integrate mission-aligned policy expertise and political acumen into planning and executing your goals.

Colorado state house

Government Contracting

Track record of success supporting states and municipalities in innovating or launching new programs.

Our proprietary method for tracking, aggregating, and analyzing state policy trends.

If you believe that every American deserves to be healthy and well, contact Impact Health Policy Partners to learn how our expertise can help you achieve your goals.

Policy Hub, managed by Impact Health Policy Partners, is the only comprehensive database of Federal health policy developments, cataloged by over 200 healthcare topics and programs. Regulations, reimbursement, grants, ACA implementation, hearing summaries, CRS Reports, pending legislation – you get it all here, with comprehensive, expert analysis.

Committee Questions FDA Commissioner Nominee on Vaccines, Political Interference, Mifepristone, and More

Today, the Senate Committee on Health, Education, Labor, and Pension (HELP) held a hearing to consider the nomination of Dr. Heidi Overton to serve as the Commissioner of the Food and Drug Administration (FDA). Additional details on the hearing follow. The HELP Committee was also scheduled to vote on the nominations of Nicole Saphier as Surgeon General, Timothy Westlake as… (Slifer, September 24, 2026) #Food and Drug Administration, #Prescription Drugs, #Program Integrity, #Public Health, #Transparency

RFI Issued on Medicare Part D Reasonable and Relevant Pharmacy Contracting Standards; Comments Due November 23

The Centers for Medicare and Medicaid Services (CMS) issued a request for information (RFI) on establishing standards for reasonable and relevant pharmacy contract terms and conditions in Part D, pursuant to section 6223 of the Consolidated Appropriations Act (CAA) of 2026 which requires Part D plan sponsors to permit any pharmacy that meets such standards to participate as a network… (Slifer, September 23, 2026) #Medicare Part D, #Pharmacies, #Pharmacy Benefit Managers, #Prescription Drugs

At Impact Health Policy Partners, we are committed to improving health for all by partnering with visionary organizations to advance well-being and expand access to more equitable, cost-effective, quality care. This starts from within, including intentional application of diversity, equity, and inclusion practices in every client and government encounter.